SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 153 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $33,291,000 | +2.3% | 2,972,383 | +0.5% | 0.00% | 0.0% |
| Q2 2017 | $32,532,000 | +12.6% | 2,957,371 | +0.3% | 0.00% | +100.0% |
| Q1 2017 | $28,899,000 | -0.9% | 2,948,846 | +9.2% | 0.00% | -50.0% |
| Q4 2016 | $29,161,000 | +9.3% | 2,700,061 | +3.7% | 0.00% | 0.0% |
| Q3 2016 | $26,686,000 | -16.3% | 2,603,520 | +6.7% | 0.00% | 0.0% |
| Q2 2016 | $31,881,000 | +47.5% | 2,441,072 | +24.3% | 0.00% | +100.0% |
| Q1 2016 | $21,610,000 | +31.1% | 1,964,600 | +9.6% | 0.00% | 0.0% |
| Q4 2015 | $16,487,000 | +39.6% | 1,792,036 | +5.3% | 0.00% | – |
| Q3 2015 | $11,807,000 | -39.7% | 1,701,386 | -14.7% | 0.00% | -100.0% |
| Q2 2015 | $19,579,000 | +12.2% | 1,993,796 | +1.2% | 0.00% | 0.0% |
| Q1 2015 | $17,448,000 | +9.8% | 1,969,187 | +8.5% | 0.00% | 0.0% |
| Q4 2014 | $15,893,000 | +57.5% | 1,814,363 | +23.9% | 0.00% | 0.0% |
| Q3 2014 | $10,088,000 | +31.5% | 1,464,252 | +0.4% | 0.00% | 0.0% |
| Q2 2014 | $7,669,000 | +15.6% | 1,457,968 | +0.0% | 0.00% | 0.0% |
| Q1 2014 | $6,633,000 | -5.2% | 1,457,849 | +5.0% | 0.00% | 0.0% |
| Q4 2013 | $6,999,000 | +0.8% | 1,388,654 | +1.4% | 0.00% | 0.0% |
| Q3 2013 | $6,943,000 | +4.5% | 1,369,376 | +2.2% | 0.00% | 0.0% |
| Q2 2013 | $6,644,000 | – | 1,339,519 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|